Invited commentary  by Bandyk, Dennis F.
We do not have a long-term patency, because we started using
duplex guidance for lower extremity angioplasties only 20 months
ago.
We did not compare results of these procedures with bypasses.
We did not yet perform comparison with standard x-ray–guided
angioplasties done in our institution. But our feeling is that the
technical success of duplex-guided angioplasties is higher. In a num-
ber of failed attempts on fluoroguided subintimal dissections, wewere
able to succeed with duplex guidance. We also used duplex assistance
in multiple cases when the arteries were obscured by joint prosthesis
or when fluoroscopy and dye were not providing adequate informa-
tion about the hemodynamic significance of the lesions.We think that
hemodynamic assessment allowed by duplex scanning adds valuable
information about the adequacy of the procedure and the significance
of technical defects as compared to x-ray.
Dr Samuel Ahn (Los Angeles, Calif). I rise to congratulate the
authors on what I think is a significant advance in endovascular
therapies. The issue of contrast exposure is going to become more
important as our patients get older and our diabetic population
continues to increase and patients are treated at more advanced
disease states, especially with congestive heart failure.
Also, the issue of radiation is real, as you pointed out. And if
you don’t believe it, put a lead apron on a patient and put the
fluoro on, and you can see right through the lead apron. It does not
protect you very well if you’re in the direct line of fire.
I was intrigued by your 4.5% thrombosis rate. I have not seen
that in my own experience, and I was curious as to why you had
such a high thrombosis rate. Is it because the ultrasound picks up
more of it and I’mmissing it with conventional fluoro? Or is it that
the technique somehow leads to more thrombotic complications?
For instance, when you put your catheters and balloons in, does it
stay in longer? Under fluoro, you just zip those catheters right in
because you can see over a wide field. In ultrasound, you’re seeing
only a very small field. Does that field-of-view limitation provide
any disadvantages of this technique?
This technique also allows you to do some tremendous hemo-
dynamic studies. Have you done any? Have you looked at the flow
velocities after completion of your procedure and correlated the
flow dynamics with your subsequent long-term or intermediate
results? For example, with higher flow rates, were your results
better? The lower the flow rates, were your results worse in the
intermediate and long term?
Finally, you didn’t mention anything about using ultrasound to
look at your closures. Do you use closure devices? And if you do use
closure devices, is the ultrasound helpful in putting the devices in and
alsomaking sure that you have goodhemostasis at the end of the case?
DrMarks.Regarding the high thrombosis rate, I couldmention
two caseswhere anesthesia residents forgot to give heparin to patients,
which dramatically increased our thrombosis incidence.
We routinely do a complete duplex study including all infrap-
opliteal arteries before and after the procedure. I have a feeling that
sometimes duplex can identify nonocclusive clots that angio would
have missed because of uniplanar imaging.
Duplex guidance of the lower extremities angioplasties in our
experience did not prolong the procedure time (average, 55 min-
utes; range, 14-180 minutes).
We do obtain hemodynamic parameters before, during, and
after procedures. Recoils and dissections are routinely assessed by
spectral analysis and stented when the peak systolic velocity ratio
across the stenosis is more than 2.
We alsomeasure volume flow in the popliteal artery before and
after procedure and after a bolus of 30 mg of papaverine to observe
the popliteal flow response to distal vasodilation.
We agree with your observation that patients with lower flows
have a tendency to thrombose the angioplastied arteries sooner;
usually these are patients with disadvantaged runoff. We are col-
lecting these data and will report our experience in the future.
We do not feel that the insonation field is limited, because we
monitor the arteries along the entire wire length every few minutes
during the procedure, which is probably more often than with
fluoroscopy. Regarding your question about the arterial closure
devices, we started using the VasoSeal closure device only in the
last five cases. The benefits of duplex scanning for arterial closure
devices are not quite clear for us at this point. We think that it can
help in the measurements of arterial depth but cannot visualize the
artery when collagen plug is in place because of air presence.
INVITED COMMENTARY
Dennis F. Bandyk, MD, Tampa, Fla
The use of color duplex ultrasonography scanning to provide
the necessary imaging to perform peripheral angioplasty proce-
dures is an important application. Monitoring arterial puncture,
guidewire manipulation, including re-entry distal to an occlusion,
measurement of vessel diameter, balloon angioplasty, or stent
deployment is possible with high-resolution B-mode imaging and
color Doppler imaging. I have used this technique, for example, to
treat vein graft or superficial femoral artery stenosis with balloon
angioplasty and can attest to its simplicity and the adequacy of
imaging to monitor an infrainguinal procedure. An advantage of
this technique over arteriography is the capability to assess the
hemodynamics of the angioplasty site.
In the article by Asher et al, sites of residual stenosis were
identified by color Doppler imaging using a threshold peak systolic
velocity ratio 2 for additional balloon angioplasty or stent deploy-
ment under ultrasound guidance. I also use a peak systolic velocity
180 to 200 cm/s as a threshold for further intervention. The use of
duplex assessment led to stenting after angioplasty in 65% of Ascher
and colleagues’ cases, a higher than expected rate, but this is also
dependent on lesion type treated and interventionist bias.
Poor resolution ultrasound imaging can be frustrating, so careful
patient and lesion selection is important. Ascher et al correctly empha-
size the need for a high level of expertise in peripheral arterial imaging
as well as avoiding calcified arterial segments and obese patients. I
believe it is best to perform preprocedure duplex imaging and select
patients according to the findings and adequacy of the study.
The technique of ultrasound-guided angioplasty is well de-
scribed by Ascher et al, including when fluoroscopic assistance was
necessary to complete the duplex-guided angioplasty or to perform
concomitant iliac artery angioplasty. Limitations of duplex-guided
angioplasty are the small field of imaging (typically 4 cm, the length
of the linear array transducer), poor recognition of artery wall
perforation by the guidewire, and inability to detect distal throm-
boembolism. Comments on the benefits of avoiding angiographic
contrast media and concerns for renal failure are interesting but not
relevant to most patients treated.
Their technical success of treating 253 atherosclerotic oc-
clusive lesions was high—overall 93%—but less when treating
TransAtlantic Inter-Society Consensus (TASC) D lesions (74%)
or attempting to perform subintimal angioplasty. The incidence
of duplex-detected residual stenosis after the procedure was not
provided by Ascher et al, thus it is not clear if this technique
results in a “better” angioplasty, immediately or long term.
Surprisingly, the authors did not comment on the number of
reinterventions performed during mean 10-month follow-up pe-
riod. The primary patency rates based on lesion type treated were
similar to other reports of infrainguinal angioplasty using arteriog-
raphy. I was left wondering why certain procedures failed and what
the postprocedural duplex scans showed at 1 month and thereaf-
ter? We can hope that these questions will be the subject of future
reports.
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